0.35Open0.20Pre Close66 Volume192 Open Interest18.00Strike Price780.00Turnover1408.24%IV1.23%PremiumDec 20, 2024Expiry Date0.13Intrinsic Value100Multiplier-1DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type-0.6854Delta0.7106Gamma51.06Leverage Ratio-62.0083Theta0.0000Rho-34.99Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet